Copyright
©The Author(s) 2025.
World J Gastroenterol. Nov 7, 2025; 31(41): 110367
Published online Nov 7, 2025. doi: 10.3748/wjg.v31.i41.110367
Published online Nov 7, 2025. doi: 10.3748/wjg.v31.i41.110367
Figure 1 Correlation analysis of pescadillo ribosomal biogenesis factor 1 expression with immune markers in gastric cancer from The Cancer Genome Atlas database.
A: Scatter plot showing the correlation between pescadillo ribosomal biogenesis factor 1 expression (log2-transformed) and CD8+ T cell infiltration levels in gastric cancer tissues; B: Scatter plot demonstrating the correlation between programmed death-ligand 1 expression and pescadillo ribosomal biogenesis factor 1 expression in gastric cancer samples. PES1: Pescadillo ribosomal biogenesis factor 1.
Figure 2 Proposed molecular mechanisms underlying pescadillo ribosomal biogenesis factor 1-mediated regulation of programmed death-ligand 1 expression and tumor immune evasion.
Created with Figdraw.com. PD-L1: Programmed death-ligand 1; PES1: Pescadillo ribosomal biogenesis factor 1; PD-1: Programmed cell death protein 1; mTORC: Mechanistic target of rapamycin complex; AKT: Protein kinase B; PDK1: 3-phosphoinositide dependent protein kinase-1; PIP2: Phosphatidylinositol 4,5-bisphosphate; PIP3: Phosphatidylinositol (3,4,5)-trisphosphate; PTEN: Phosphatase and tensin homolog; BRD4: Bromodomain-containing protein 4; c-Myc: Myelocytomatosis oncogene.
- Citation: Yu J, Yu B, Ge FL, Ren ZG. Pescadillo ribosomal biogenesis factor 1 as a therapeutic target in tumor immunotherapy. World J Gastroenterol 2025; 31(41): 110367
- URL: https://www.wjgnet.com/1007-9327/full/v31/i41/110367.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i41.110367
